HIRA to regulate high-priced drugs

The Health Insurance Review Agency (HIRA) said at a meeting with parliamentary committee of health and welfare on April 21 that the agency will push to discourage the use of high-priced prescription drugs in the medical institutions and reduce the prescription number of branded items this year, in parallel with the implementation of the national campaign program for the prevention of misuse or ...